How to Cite
Abstract
The Behçet´s disease (BD) is an inflammatory multisystemic vasculitis of unknown etiology and is classified as a rare disease in the USA and European countries. The spectrum of neurologic involvement is wide, however the clinical manifestations and the results of neuroimaging support two major forms of Neuro-Behçet syndrome: parenchymal and non-parenchymal. The BD must be included in the differential diagnosis of inflammatory, vascular and demyelinating diseases of the central nervous system.
Keywords
References
Caruso P, Moretti R. Focus on neuro-Behçet's disease: A review. Neurol India. Nov, 2018; 66(6):1619-1628. Doi: https://doi.org/10.4103/0028-3886.246252
Houman MH, Bellakhal S, Salem TB, Hamzaoui A, Braham A, Lamloum M, et al. Characteristics of neurological manifestatios of Behçet's disease: a retrospective monocentric study in Tunisia. Clinical Neurology and Neurosurgery. Oct 2013;115(10):2015-2018. Doi: https://doi.org/10.1016/j.clineuro.2013.06.009
Saip S, Akman G, Siva A. Handbook of Clinical Neurology, Chapter 10: Neuro Behcet syndrome. Elsevier 2014; 121.
Cagri E, Sari A, Kilic L, Kalyoncu U, Kurne A, Oguz KK, Akif M, Ertenli I, Karadag O. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience. Multiple sclerosis and related disorders. Feb, 2020;38(1):1-7. Doi: https://doi.org/10.1016/j.msard.2019.101512
Borhani A, Kardeh B, Banerjee S, Yadollahikhales G, Safari A, Ali M, Shapiro L. Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and Treatment. Multiple sclerosis and related disorders. Dec, 2020;39(1):1-15. Doi: https://doi.org/10.1016/j.msard.2019.101906
López A, Parra C, Bellosta E, Cecilio A, Santos S. Manifestaciones neurológicas de la enfermedad de Behcet: descripción de un caso y revisión de la literatura. Reumatología clínica. Sep, 2019;15(5):36-38. Doi: https://doi.org/10.1016/j.reuma.2017.04.009
Hayriye M, Aykut M, Yucesan C. Clinical characteristics and prognosis of Neuro-Behçet’s disease. Eur J Rheumatol. Dec, 2018;5(4):235-9. Doi: https://doi.org/10.5152/eurjrheum.2018.18033
Siva A, Saip S. The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis. Journal of Neurology. Apr, 2009;256(4):513–529. Doi: https://doi.org/10.1007/s00415-009-0145-6
Fountain E, Dhurandhar A. Neuro-Behçet’s Disease: An Unusual Cause of Headache. Journal of General Internal Medicine. Feb, 2014;29(6):956–960. Doi: https://doi.org/10.1007/s11606-014-2781-5
Casanova I, De las Heras V, Parejo B, Di Capua D, Fuentes E, García R, Arroyo R. Neurobehçet disease: clinical and demographic characteristics European Journal of Neurology. Apr, 2012;19(9):1224–1227. Doi: https://doi.org/10.1111/j.1468-1331.2012.03706.x
Saip S, Akman G, Siva A. Neuro-Behçet syndrome. Neurologic Aspects of Systemic Disease Part III. 2014:1703–1723. Doi: https://doi.org/10.1016/B978-0-7020-40887.00110-3
Diri E, Espinoza LR. Neuro-behçet’s syndrome: Differential diagnosis and management. Curr Rheumatol Rep. Aug, 2006;8(4):317–322. Doi: https://doi.org/10.1007/s11926-006-0016-4
Uygunoğlu U, Siva A. Behçet’s Syndrome and Nervous System Involvement. Curr Neurol and Neurosci Rep. May, 2018;18(7):35. Doi: https://doi.org/10.1007/s11910-018-0843-5
Kalra S, Silman A, Akman-Demir G, Bohlega S, Borghani-Haghighi A, Constantinescu CS, Houman H, Mahr A, Salvarani C, Sfikakis PP, Siva A, Al-Araji A. Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations. Journal of Neurology. Sep, 2014;261(9):1662–1676. Doi: https://doi.org/10.1007/s00415-013-7209-3
Mohamed C, Najib K, Essaadouni L. Radiological findings in Behçet disease. Pan African Medical Journal. Jan, 2015;20(51). Doi: https://doi.org/10.11604/pamj.2015.20.51.5928
Yin L, Riminton DS, Nguyen M, Barnett MH, Reddel SW, Hardy TA. The spectrum of immune-mediated and inflammatory lesions of the brainstem: Clues to diagnosis. Neurology. Aug, 2019;93(9):390-405. Doi: https://doi.org/10.1212/WNL.0000000000008015
Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G, et al. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Annals of Neurology. Jan, 2018; 83(2);283-294. Doi: https://doi.org/10.1002/ana.25146
Saleh Z, Arayssi T. Update on the therapy of Behçet disease. Therapeutic Advances in Chronic Disease. May, 2014; 5(3): 112–134. Doi: https://doi.org/10.1177/2040622314523062
Arida A, Fragiadaki K, Giavri E, Sfikakis P. Anti-TNF agents for Behcet’s disease: analysis of published data on 369 patients. Semin Arthritis Rheum. Aug, 2011;41(1):61–70. Doi: https://doi.org/10.1016/j.semarthrit.2010.09.002
Davatchi F, Shams H, Rezaipoor M, Sadeghi-Abdollahi B, Shahram F, Nadji A, Chams-Davatchi C, Akhlaghi M, Faezi T, Naderi N. Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study). International Journal of Rheumatic Diseases. Aug, 2010;13(3):246–252. Doi: https://doi.org/10.1111/j.1756-185X.2010.01546.x
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2022 Array